Use of Subclavian Extracorporeal Carbon Dioxide Removal for COVID-19 Acute Respiratory Distress Syndrome as a Bridge to Lung Transplantation.

Severe acute hypercapnia is independently associated with increased adverse effects and intensive care unit mortality in mechanically ventilated patients. During the severe acute respiratory syndrome coronavirus 2 (COVID-19) pandemic, some patients were placed on extracorporeal carbon dioxide removal support when extracorporeal membrane oxygenation (ECMO) support was at capacity or not offered. We present a patient with severe acute respiratory distress syndrome caused by COVID-19 pneumonia, who was supported with Hemolung Respiratory Assist System (ALung Technologies, Inc., LivaNova, Pittsburgh, PA) via the right subclavian vein as a bridge to lung transplantation after venovenous ECMO support. The patient survived and was discharged home.

[1]  G. Perkins,et al.  Effect of Lower Tidal Volume Ventilation Facilitated by Extracorporeal Carbon Dioxide Removal vs Standard Care Ventilation on 90-Day Mortality in Patients With Acute Hypoxemic Respiratory Failure: The REST Randomized Clinical Trial. , 2021, JAMA.

[2]  Xiaowei Yan,et al.  ECCO2R in 12 COVID-19 ARDS Patients With Extremely Low Compliance and Refractory Hypercapnia , 2021, Frontiers in Medicine.

[3]  John M Litell,et al.  Treatment of Severe Hypercapnic Respiratory Failure Caused by SARS-CoV-2 Lung Injury with ECCO2R Using the Hemolung Respiratory Assist System , 2021, Case Reports in Critical Care.

[4]  J. Richecoeur,et al.  Feasibility and safety of ultra-low tidal volume ventilation without extracorporeal circulation in moderately severe and severe ARDS patients , 2019, Intensive Care Medicine.

[5]  J. Sznajder,et al.  Severe hypercapnia and outcome of mechanically ventilated patients with moderate or severe acute respiratory distress syndrome , 2017, Intensive Care Medicine.

[6]  P. Kalfon,et al.  Intravascular Complications of Central Venous Catheterization by Insertion Site. , 2015, The New England journal of medicine.

[7]  H. Teschler,et al.  Avoidance of intubation during acute exacerbation of chronic obstructive pulmonary disease for a lung transplant candidate using extracorporeal carbon dioxide removal with the Hemolung. , 2013, The Journal of thoracic and cardiovascular surgery.

[8]  L. Gattinoni,et al.  THE CARBON DIOXIDE MEMBRANE LUNG (CDML): A NEW CONCEPT , 1977, Transactions - American Society for Artificial Internal Organs.